Safeguarding Patient Trust in the Age of AI: Tackling Health Misinformation with Explainable AI

Brianna Bao; Francesa Toni; Guy Martin; James Kinross; Ovidiu Serban; Shuojie Fu; Sueun Hong; Uddhav Vaghela

REVIEW 4 major objections 4 minor 7 references

Safeguarding Patient Trust in the Age of AI: Tackling Health Misinformation with Explainable AI

T0 review · 4 major / 4 minor · reviewed 2026-08-05 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Explainable AI claims to compress six-month guideline reviews into real-time evidence synthesis while keeping clinical oversight.

desk verdict A white paper that describes a plausible RAG pipeline for guideline evidence retrieval but whose headline transformation claim rests on an undefined synthetic benchmark; fine as a project overview, not as evidence. read the letter →

arxiv 2509.04052 v1 pith:4EUE3HJX submitted 2025-09-04 cs.IR

Sueun Hong , Shuojie Fu , Ovidiu Serban , Brianna Bao , James Kinross , Francesa Toni , Guy Martin , Uddhav Vaghela This is my paper · ORCID

classification cs.IR

keywords healthmisinformationexplainableAIclinicalevidenceretrievalretrieval-augmentedgenerationguidelinesynthesisdetectiontrustworthinessclassificationinfodemic

verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Health misinformation is now automated, and the paper argues that the same AI tools that generate false medical content can be repurposed to protect evidence-based medicine. Its proposed pipeline retrieves relevant clinical publications from a continuously updated vectorized knowledge base, reranks them, filters them through trustworthiness and argument-explanation classifiers, and has an LLM synthesize answers strictly from retrieved evidence. On a benchmark built with the UK guideline authority, it reports 95% recall for evidence retrieval, alongside a biomedical trustworthiness classifier with 76% F1 and over 80% recall for research fraud. The paper presents this as evidence that a process that normally takes six months and many experts can be collapsed to near real-time without sacrificing clinical rigor, provided clinicians stay in the loop for final checks.

What carries the argument

Retrieval-Augmented Generation (RAG) pipeline: a continuously updated vectorized knowledge base of biomedical publications, query embedding with similarity search, Cross-Encoder reranking, and two explainability/verification components—a biomedical trustworthiness classifier (PubGuardLLM) and an argumentative LLM verifier (argLLM) that outputs structured, contestable explanations. The load-bearing idea is that the LLM is forbidden from using prior knowledge, so every sentence in a synthesized guideline answer must trace to a retrieved publication that has survived veracity screening.

What would settle it

Run the same retrieval pipeline on a completed guideline update where the expert committee's actual inclusion list is known, and compare recall against that real list rather than the synthetic benchmark. If recall drops below the reported 95%, or if a blinded panel of clinicians rates the automated syntheses as less clinically sound than the committee's own summaries, the paper's claim that rigor survives automation is refuted.

Watch

Extended reading notes

Core claim

The paper's central claim is that clinical evidence synthesis, the bottleneck in guideline production, can be largely automated while remaining explainable and clinically safe. The mechanism is a retrieval-augmented generation pipeline: open-access biomedical articles are embedded and indexed continuously; a query is embedded, matched, reranked, and then filtered by two AI components that assign veracity scores and provide structured, auditable explanations. Only the surviving evidence is given to an LLM, which is instructed to answer using no prior knowledge; clinicians rank the outputs. The reported results—95% retrieval recall on a synthetic benchmark built with the guideline authority, 7

Load-bearing premise

The benchmark built with the guideline authority is a faithful stand-in for the real expert review process; if 95% recall only holds on that synthetic set and not on actual expert-curated guideline references, the speed-without-rigor-loss claim collapses.

Editorial extensions

If this is right

Guideline production could shift from periodic six-month review cycles to a continuously updated evidence base that responds to new publications within weeks.
Every synthesized clinical answer remains auditable: the LLM's output is tied to specific retrieved and screened publications, so clinicians can trace claims to sources.
Misinformation screening becomes a quantitative gate: publications failing veracity checks are deprioritized or removed before evidence synthesis, rather than relying solely on expert intuition.
The system does not remove human oversight; it redirects expert time toward low-confidence and high-stakes cases, with clinicians ranking final outputs.
Adapting the pipeline to other clinical areas requires little more than building the evidence database for that area and re-running the retrieval and screening stages.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

The 95% recall figure is measured on a synthetic benchmark; real-world deployment would need publisher-side access to paywalled literature, because the paper's own error analysis lists paywall-restricted documents as a source of omissions.
A sharper test of 'maintaining clinical rigor' would compare the automated inclusion/exclusion decisions against the actual decisions of a full expert guideline committee, not just against a synthetic set.
If the retrieval recall generalizes, the future bottleneck shifts from finding evidence to verifying it, and the most valuable expert time may move from screening to adjudicating borderline veracity scores.
The same pipeline could be inverted as a patient-facing tool, but that would require re-evaluating the trade-off between speed and the harms of a false negative in a consumer setting.

Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Desk Editor's Note

read the letter

The one thing to know: this is a white paper, not a research study. The abstract says 95% recall on a “synthetic benchmark collaboratively developed with NICE” and claims the system can collapse a six-month expert review into seconds while preserving rigor, but the benchmark is not described (no size, no labels, no split, no release), and Section 7 openly says that evaluation at scale is still “predominantly manual and heavily dependent on human expert involvement.” That last admission is the paper's own best counter-evidence to the transformation claim.

What's genuinely there: a clean description of a plausible retrieval-and-synthesis pipeline (PubMedBERT embeddings, cross-encoder reranking, LLM synthesis with no prior knowledge, human-in-the-loop checks). The authors test multiple encoder/similarity configurations against reference data and report an error analysis (e.g., missing Pembrolizumab as a chemotherapy agent, paywall-related gaps). That is honest engineering reporting. The systematic review of 17 studies is thin but does not overstate itself.

Where it falls short: the central claim is not supported by the released evidence. The 95% recall number is uninterpretable without benchmark details, and the two “novel trustworthiness classifiers” (PubGuardLLM and argLLM) are from the same group and cited as published work; their F1 scores are not evaluations performed in this paper. No code, data, or protocol are provided, so the result is not independently checkable. The paper also drifts into regulatory and strategic commentary, which is fine for a white paper but should not be mistaken for evaluation.

If you give it to a referee, they would rightly demand: full benchmark specification, a comparison against real NICE gold-standard references, and a direct comparison of end-to-end pipeline outputs with actual NICE guidelines. Without those, the “maintaining clinical rigor” clause has no evidentiary basis. That said, the paper is honest about its own limitations in Section 7, so I'd classify this as an overclaiming project summary rather than a deceptive one.

My recommendation: desk reject for peer review. It might be useful as a project overview for stakeholders or as a starting point for internal discussion, but as a scientific paper it doesn't meet the bar. I would not cite it in my own work, and I wouldn't take it to reading group except as an example of why benchmark transparency matters.

Referee Report

4 major / 4 minor

Summary. This white paper describes an explainable-AI framework from the EPSRC INDICATE project that combines semantic retrieval, veracity classification, and LLM-based synthesis for evidence-based healthcare. It reports a systematic review of 17 studies on AI and health misinformation, a 95% retrieval recall on a benchmark described as 'synthetic' and 'collaboratively developed with NICE,' and integrates two classifiers (PubGuardLLM and argLLM) with cited F1 scores of 76% and 90%+. The abstract and conclusion claim that this approach can replace NICE's six-month expert review process with real-time automated evidence synthesis while maintaining clinical rigor. The paper also discusses UK regulatory alignment and ethical/legal considerations.

Significance. If the central claim were substantiated, the contribution would be significant: automating or substantially accelerating NICE-style evidence review while preserving clinical rigor would have clear practical value. The paper usefully connects retrieval, veracity checking, and argumentative explainability, and it engages with the UK regulatory landscape. However, the evidence presented is not sufficient: the key benchmark is not described, the end-to-end system is not compared with actual NICE outputs, and the headline classifier scores come from companion papers by the same group rather than from evaluation in this framework. The manuscript therefore reads as a proposal or project overview rather than a demonstrated result.

major comments (4)

[Section 4, Stage 1; Section 7] The central claim—that the framework 'can transform traditional 6-month expert review processes into real-time, automated evidence synthesis while maintaining clinical rigor'—is unsupported. The only direct evidence is the 95% recall figure, but the manuscript does not specify the synthetic benchmark's construction: no sample size, query count, label generation protocol, split, or release. Stage 1 measures retrieval only, not the end-to-end pipeline against NICE guideline outputs. Section 7 explicitly states that evaluation at scale is 'predominantly manual and heavily dependent on human expert involvement,' directly contradicting the claimed automated transformation. The claim must be either substantially supported or withdrawn.
[Section 4, Advanced Verification and Trustworthiness Models] The 76% F1 for PubGuardLLM and 90%+ F1 for argLLM are cited from companion papers by the same research group (Chen et al. 2025; Freedman et al. 2025), not evaluated here. No datasets, baselines, or integration results are reported. Since the abstract repeats these figures as part of 'our proposed solution,' the trustworthiness argument is self-referential: the system is validated using classifiers developed by the same team, with no independent assessment or evidence that the classifiers work in the proposed pipeline.
[Section 4, Stage 2] The 'Biomedical Answer Synthesis Quality' objective is not met because no results are reported. The methodology says one clinical question, three supporting publications, eight LLMs, and a blinded clinician panel, but the actual rankings, inter-rater agreement, and any comparison to a NICE reference answer are absent. Without these data, the 'clinical rigor' component of the central claim has no empirical support.
[Sections 2–3] The described workflow includes multiple human steps: 'The human experts then joined the process to read the retrieved passages and assign relevancy and curation scores' and 'The outputs were reviewed by a team of clinicians.' This is inconsistent with the claim of a 'real-time, automated' process. The paper should clearly specify which version (human-in-the-loop vs. fully automated) was evaluated and report the human effort required for the claimed transformation.

minor comments (4)

[Section 3] The systematic review of 17 studies is mentioned but no PRISMA flow diagram, list of included studies, exclusion details, or synthesis is provided. As reported, the 'systematic review' claim is unverifiable.
[Section 4, Stage 1 Error Analysis] The error analysis cites 'failing to identify Pembrolizumab as a chemotherapy agent.' Pembrolizumab is an immune checkpoint inhibitor, not a chemotherapy agent; this characterization is technically inaccurate and makes the analysis confusing.
[Section 4, Stage 2] The text says 'eight open-source LLMs (including variants of LLaMA, Mistral, and Claude).' Claude is not open-source; this should be corrected to 'eight LLMs' or the list adjusted.
[References] Reference formatting is inconsistent: several URLs lack access dates, and the author list contains 'Francesa Toni' (likely a typo for Francesca Toni). Please use a single consistent citation style throughout.

Circularity Check

1 steps flagged · score 4.0 of 10

Trustworthiness evidence is self-cited, and the headline 95% recall benchmark is under-specified; the central transformation claim lacks independent audit.

self citation load bearing [Section 4, 'Advanced Verification and Trustworthiness Models' (also abstract and references [Chen et al., 2025], [Freedman et al., 2025])]
"We integrated two novel AI components: • PubGuardLLM – Biomedical Trustworthiness Classifier (Chen et al., 2025) Developed to detect misinformation and low-quality publications, PubGuardLLM achieves: o 76% F1 score across multiple biomedical datasets o >80% recall in detecting research fraud - without external supervision, indicating strong generalisation and standalone robustness. • argLLM – Structured Explainability & Claim Validation Model (Freedman et al., 2025) Integrated to provide transparent reasoning and verifiable outputs, argLLM enables structured, auditable answer explanations with"

Both cited works share authors with this paper: Chen et al. 2025 includes Fu, Martin, Kinross, Vaghela, Serban, and Toni; Freedman et al. 2025 includes Toni. The current paper does not re-run or independently audit these classifiers; it imports their published F1/recall numbers as evidence for the 'novel trustworthiness classifiers' and for the abstract's claim that the framework maintains 'clinical rigor.' Thus the trustworthiness portion of the central claim is supported by a self-citation chain rather than by evidence generated in this paper. This is load-bearing self-citation, not independent external validation.

full rationale

The retrieval evaluation is partly external: Stage 1 uses four clinical questions from NICE NG101 and a benchmark 'collaboratively developed with NICE,' and Stage 2 uses blinded clinician review. The paper also states that the retrievers were 'fine-tuned on independent datasets, so the final selection is not biased in any way.' Those elements give the retrieval result some independent content and mean the paper is not definitionally circular. However, the 'trustworthiness' components (PubGuardLLM and argLLM) are reported entirely by self-citation to prior works by the same research group, with no re-evaluation in this white paper, so the abstract's claim that the solution 'integrates novel trustworthiness classifiers achieving 76% F1' and can maintain 'clinical rigor' rests on a self-citation chain. Additionally, the 95% recall figure is reported only on an unspecified 'synthetic benchmark collaboratively developed with NICE'; the paper does not state the benchmark's size, construction, label protocol, or release, and it never compares the full retrieval-verification-synthesis pipeline against actual NICE guideline outputs. Section 7 further concedes that at-scale evaluation is 'predominantly manual and heavily dependent on human expert involvement,' which undercuts the headline claim that the 6-month expert process has already been transformed into real-time automated synthesis. These are missing-support problems that compound the self-citation concern, but because the core retrieval benchmark retains independent external components and the retrievers are said to be fine-tuned on independent data, the appropriate score is 4 rather than 6 or higher.

Assumptions & free parameters 2 free parameters · 4 assumptions · 0 invented entities

The framework depends on a set of unverified domain assumptions, particularly the validity of the synthetic NICE benchmark, the effectiveness of the LLM anti-hallucination instruction, and the reliability of self-cited classifiers. No free parameters are reported, and the system's headline metrics rest on undisclosed configuration choices.

free parameters (2)

Retrieval configuration (top-K, similarity metric, encoder choice) = Not reported
The authors tested multiple encoder and similarity metric combinations and selected the best performer, but the final configuration and hyperparameters are not disclosed, so the reported 95% recall depends on an unstated choice.
Veracity score threshold = Not reported
The automated veracity check pipeline assigns scores and eliminates low-veracity publications, but the threshold is not specified, making the evidence filtering non-reproducible.

assumptions (4)

domain assumption The NICE synthetic benchmark is a faithful proxy for the real clinical evidence review gold standard.
Section 4 Stage 1: 95% recall is measured on a 'synthetic benchmark collaboratively developed with NICE', but the benchmark's construction and equivalence to real expert review are not described.
domain assumption Instructing the LLM to ignore prior knowledge substantially reduces hallucination.
Section 3: 'The LLM was forbidden to use prior knowledge so that hallucination could be reduced to a great degree.' No evidence is provided to support this claim.
domain assumption Human-in-the-loop checks ensure the quality and clinical rigor of the synthesized answers.
Section 2 and 3 state human experts review outputs, but the paper does not measure whether this catches errors or preserves rigor.
domain assumption PubGuardLLM and argLLM, as described in the authors' prior papers, reliably detect misinformation and provide trustworthy explanations.
Section 4 relies on F1 scores from Chen et al. 2025 and Freedman et al. 2025, both with overlapping authorship, as evidence of framework reliability without independent validation in this paper.

how reviews work

0 comments

Cite this review

Pith. "Pith review of Safeguarding Patient Trust in the Age of AI: Tackling Health Misinformation with Explainable AI." pith.science (2026). https://pith.science/paper/4EUE3HJX

@misc{pith2026250904052,
  author       = {Pith},
  title        = {Pith review of: Safeguarding Patient Trust in the Age of AI: Tackling Health Misinformation with Explainable AI},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/4EUE3HJX}},
  note         = {Machine review of arXiv:2509.04052}
}

read the original abstract

AI-generated health misinformation poses unprecedented threats to patient safety and healthcare system trust globally. This white paper presents an explainable AI framework developed through the EPSRC INDICATE project to combat medical misinformation while enhancing evidence-based healthcare delivery. Our systematic review of 17 studies reveals the urgent need for transparent AI systems in healthcare. The proposed solution demonstrates 95% recall in clinical evidence retrieval and integrates novel trustworthiness classifiers achieving 76% F1 score in detecting biomedical misinformation. Results show that explainable AI can transform traditional 6-month expert review processes into real-time, automated evidence synthesis while maintaining clinical rigor. This approach offers a critical intervention to preserve healthcare integrity in the AI era.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

7 extracted references · 7 canonical work pages

[1]

infodemic

The Misinformation/Infodemic Crisis in Healthcare and Implications for Patient Safety & Health System Trust With the advent of generative artificial intelligence, a new era of sophisticated but potentially dangerous medical disinformation has begun, endangering patient safety and international health systems. AI generative platforms can potentially improv...

work page 2020
[3]

Our systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines(Moher et al., 2009)

Methodology of the White Paper - Systematic Review A systematic review explored the current state of AI-driven health misinformation. Our systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines(Moher et al., 2009). We conducted comprehensive searches across multiple databases, including MEDLINE,...

work page 2009
[5]

10-Year Health Plan

Impact and Benefits to Government The UK government has already recognised that AI poses threats of misleading information and recognises the need to ensure AI-generated content is trusted and safe (UK Government Department for Science, 2024). The UK government must treat health misinformation as a public health threat requiring a coordinated national res...

work page 2024
[6]

raises significant ethical and legal challenges,

Ethical and Legal Considerations Integrating AI into healthcare systems "raises significant ethical and legal challenges," requiring attention to key ethical principles—autonomy, beneficence, non-maleficence, and justice (Beauchamp & Childress, 2024). From a legal perspective, AI must include "informed consent, certification and approval as medical device...

work page 2024
[8]

Pub-Guard-LLM: Detecting Retracted Biomedical Articles with Reliable Explanations

Conclusion The convergence of artificial intelligence and health misinformation represents one of the most pressing challenges facing global healthcare systems today. As generative AI enable the creation of increasingly sophisticated yet potentially harmful medical content, the imperative for trustworthy, explainable AI solutions has never been more urgen...

work page Pith review arXiv 2024
[2024]

the growing number of places people go to for information has made it easier for misinformation to spread at a never-before-seen speed and scale,

The worldwide scale of this threat is demonstrated by several alarming examples from many healthcare areas, including vaccine misinformation, fraudulent cancer cures, and risky medical procedures. The U.S. Department of Health and Human Services notes that "the growing number of places people go to for information has made it easier for misinformation to ...

work page 2024
[2025]

When a question was received, we extracted the question embedding using an encoder that projects into the same hyperspace as the articles

were used in this step, and the results were evaluated using reference data. When a question was received, we extracted the question embedding using an encoder that projects into the same hyperspace as the articles. The question embedding was then passed into the knowledge base for similarity search, and the top K most relevant article passages were retri...

work page 2024

Pith tools

Reviewed August 5, 2026 · model on record in the stance chip above.

[1] [1]

infodemic

The Misinformation/Infodemic Crisis in Healthcare and Implications for Patient Safety & Health System Trust With the advent of generative artificial intelligence, a new era of sophisticated but potentially dangerous medical disinformation has begun, endangering patient safety and international health systems. AI generative platforms can potentially improv...

work page 2020

[2] [3]

Our systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines(Moher et al., 2009)

Methodology of the White Paper - Systematic Review A systematic review explored the current state of AI-driven health misinformation. Our systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines(Moher et al., 2009). We conducted comprehensive searches across multiple databases, including MEDLINE,...

work page 2009

[3] [5]

10-Year Health Plan

Impact and Benefits to Government The UK government has already recognised that AI poses threats of misleading information and recognises the need to ensure AI-generated content is trusted and safe (UK Government Department for Science, 2024). The UK government must treat health misinformation as a public health threat requiring a coordinated national res...

work page 2024

[4] [6]

raises significant ethical and legal challenges,

Ethical and Legal Considerations Integrating AI into healthcare systems "raises significant ethical and legal challenges," requiring attention to key ethical principles—autonomy, beneficence, non-maleficence, and justice (Beauchamp & Childress, 2024). From a legal perspective, AI must include "informed consent, certification and approval as medical device...

work page 2024

[5] [8]

Pub-Guard-LLM: Detecting Retracted Biomedical Articles with Reliable Explanations

Conclusion The convergence of artificial intelligence and health misinformation represents one of the most pressing challenges facing global healthcare systems today. As generative AI enable the creation of increasingly sophisticated yet potentially harmful medical content, the imperative for trustworthy, explainable AI solutions has never been more urgen...

work page Pith review arXiv 2024

[6] [2024]

the growing number of places people go to for information has made it easier for misinformation to spread at a never-before-seen speed and scale,

The worldwide scale of this threat is demonstrated by several alarming examples from many healthcare areas, including vaccine misinformation, fraudulent cancer cures, and risky medical procedures. The U.S. Department of Health and Human Services notes that "the growing number of places people go to for information has made it easier for misinformation to ...

work page 2024

[7] [2025]

When a question was received, we extracted the question embedding using an encoder that projects into the same hyperspace as the articles

were used in this step, and the results were evaluated using reference data. When a question was received, we extracted the question embedding using an encoder that projects into the same hyperspace as the articles. The question embedding was then passed into the knowledge base for similarity search, and the top K most relevant article passages were retri...

work page 2024